发明名称 MATERIAL AND METHOD FOR TREATING INTERNAL CAVITIES
摘要 A hydrophilic biocompatible sustained-release material is disclosed. The material comprises amounts of Pluronic F-127, PEG-400, HPMC and water, effective to produce a composition of sufficiently low viscosity at room temperature to be injectable into an internal body cavity via a tube inserted within a urinary catheter. At body temperature, the material exhibits a much higher viscosity and will stably adhere to the internal surface of a body cavity. As the material dissolves, a therapeutic agent incorporated therein is slowly released to the body cavity, while the material itself is excreted from the body.
申请公布号 US2015366974(A1) 申请公布日期 2015.12.24
申请号 US201514720676 申请日期 2015.05.22
申请人 Theracoat Ltd. 发明人 Holzer Asher;Daniel Dorit;Mullerad Michael;De La Zerda Jaime;Shpolansky Uri;Malchi Nadav;Dollberg Yosh;Tal Dor;Yavin Yossi;Konorty Marina
分类号 A61K47/34;A61K38/20;A61K38/48;A61K31/407;A61K31/704 主分类号 A61K47/34
代理机构 代理人
主权项 1. A method of treating a urinary tract cancer comprising: obtaining a pharmaceutical composition comprising an effective amount of a therapeutic agent and a thermoreversible hydrogel; wherein the thermoreversible hydrogel comprises: (i) 18% (w/w) to 40% (w/w) ethylene oxide/propylene oxide block copolymer, (ii) 0.05% (w/w) to 0.5% (w/w) HPMC, and (iii) water; and administering the pharmaceutical composition to a human in need thereof.
地址 Raanana IL